Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
New York to require social media platforms to display mental health warnings- Defense Minister Katz finally condemns Jewish extremist violence against Palestinians
- Why boosting production of Venezuela's 'very dense, very sloppy' oil could harm the environment
- Key Little Things That Advantage Old People
- NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- 5 Pizza Fixings That Characterize Your Character
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Bolsonaro discharged from hospital and placed under house arrest
- Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
